About Empirico
Empirico is a Healthcare company based in San Diego (United States) founded in 2017 by Brian Cajes and Shannon Bruse. Empirico is focused on therapeutic discovery using human genetics. It operates on a HealthTech model. Its chief executive, as recorded, is Omri Gottesman. Empirico offers products and services including Precision Medicines and siRNA Medicines. Its focus areas include Biotechnology and Precision Medicine. Its legal entity is Empirico Inc. Similar companies include AbbVie, Lilly and Biogen; 1 of its 3 listed similar companies has raised funding.
Company details
Empirico is engaged in discovering and developing novel medicines by leveraging human genetics. The company utilizes foundational technology platforms to design therapies that mimic beneficial genetic variants impacting health and disease. With expertise in siRNA medicines and external capabilities in other modalities, Empirico builds a pipeline of clinical and preclinical programs targeting common diseases with unmet needs. Research and development efforts are supported by a dedicated team of professionals across various scientific and medical fields.
Products & Services of Empirico
Empirico offers a comprehensive portfolio of products and services, including Precision Medicines and siRNA Medicines.
Medicines are developed using human genetics insights.
siRNA therapies are created for common diseases.
People of Empirico
28 people are tracked at Empirico (13 in leadership, 15 in team).
| Name | Role | Group |
|---|---|---|
Brian Cajes | Co-Founder | Leadership |
Shannon Bruse | Co-Founder & SVP | Leadership |
Omri Gottesman | CEO | Leadership |
Becca Kim | Associate Director, Research Operations And Alliance Management | Leadership |
Anggie Becorest | SVP And Head Of Operations | Leadership |
Bill McLeod | Chief Financial Officer | Leadership |
Mandy A. | Senior Director - Human Resources | Leadership |
David Rozema | Head Of Therapeutic Chemistry | Leadership |
Jason O'Rourke | Senior Director - Target Biology | Leadership |
David Lewis | Head Of Therapeutic Development | Leadership |
Gregory McInnes | Senior Director, Translational Genetics | Leadership |
David Jakubosky | Senior Director - Bioinformatics | Leadership |
Lauren Almeida | Director - Oligonucleotide Synthesis | Leadership |
Andrés Duvvuri | Full Stack Software Engineer | Team |
Katia Mickelson | Operations & AP Associate | Team |
Zachary Romer | Lead Data Infrastructure Engineer | Team |
Narayan K. | Bioinformatics Data Manager | Team |
Andrew Cicchetto | Scientist – Target Biology | Team |
Eric Buss | Senior Scientist | Team |
Eric Sung | Senior Scientist | Team |
8 more people are available in the full profile.
Complete people profiles for Empirico
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Empirico
Empirico has 3 listed similar companies in our database, 1 of them funded. They include AbbVie, Lilly and Biogen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abbvie.com | 2012 | Chicago, United States | 8,667 | Biopharmaceutical research and drug development are conducted globally by AbbVie. | ||
| lilly.com | 1876 | United States | 39,000 | Traditional pharmaceutical medicines are developed for multiple health fields. | ||
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. |
Detailed similar companies of Empirico
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Empirico
The website of Empirico (empiri.co) receives about 2.5K visits a month.
- Monthly visits2.5K
▼ 50% vs previous month
Websites whose visitors overlap most with Empirico. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| definedbioscience.com | 100% | 2.1K | #8,065,147 | View details | |
| rosalind.bio | 99% | 9.1K | #2,228,840 | View details | |
biopioneerinc.com | biopioneerinc.com | 98% | #5,300,424 | – | |
invivoscribe.com | invivoscribe.com | 95% | #2,713,213 | – | |
| abterrabio.com | 95% | 2.3K | #7,094,620 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Empirico
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Empirico (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Empirico
Complete news archive for Empirico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Empirico
Empirico was founded in 2017.
Empirico is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Omri Gottesman is the CEO of Empirico, as recorded in our data.
Empirico is engaged in discovering and developing novel medicines by leveraging human genetics. The company utilizes foundational technology platforms to design therapies that mimic beneficial genetic variants impacting health and disease. With expertise in siRNA medicines and external capabilities in other modalities, Empirico builds a pipeline of clinical and preclinical programs targeting common diseases with unmet needs. Research and development efforts are supported by a dedicated team of professionals across various scientific and medical fields.
Empirico offers Precision Medicines and siRNA Medicines.
Empirico operates through Empirico Inc..